CoChat

Placebo in Nonalcoholic Steatohepatitis: Insight Into Natural History and Implications for Future Clinical Trials

Open access
Loomba, Rohit, Wesley, Robert, Pucino, Frank, Liang, T. Jake, Kleiner, David E., Lavine, Joel E. · 2008 · Clinical Gastroenterology and Hepatology
Cited by 48

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Background and aims Changes in biochemical and histologic parameters related to nonalcoholic steatohepatitis (NASH) in placebo-treated patients may provide an insight into natural history and help in defining treatment endpoints in NASH. The aim of our study was to assess the biochemical and histologic changes seen in the placebo-arm of the randomized-placebo-controlled trials in adult patients with NASH. Methods: Data Sources Medline was searched (through May 2008) for studies published in the English language. Study Selection Randomized, placebo-controlled trials of at least 6-month duration in patients with NASH that provided biochemical and/or histologic data of placebo-arm. Data Extraction One investigator performed literature search and data extraction. Two investigators independently confirmed that the studies met pre-specified criteria. Pooled estimates of biochemical and histologic parameters associated with NASH were calculated. Results Five randomized-controlled trials met the predefined criteria and included 162 placebo-treated and 189 active-treatment patients. Mean serum alanine (ALT) and aspartate (AST) aminotransferase decrease on placebo. 1-point improvement in steatosis, ballooning degeneration, lobular inflammation, NASH fibrosis and combined inflammation scores is seen in 31%, 15%, 33%, 22% and 32% of patients, respectively. 2-point improvement in NASH histologic scores is rarely seen. Conclusions Serum ALT may decrease on placebo and is not a reliable measure of treatment response. Although a 1-point improvement is seen in a third of patients, a 2-point improvement in histologic parameters is rarely seen in placebo-arm and may be more reliable in assessing treatment response. These data may have important implications in designing future clinical trials in NASH.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cgh.2008.07.013

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 48

Metadata

Authors
Loomba, R., Wesley, R., Pucino, F., Liang, T. J., Kleiner, D. E., & Lavine, J. E.
Venue
Clinical Gastroenterology and Hepatology
Publisher
Elsevier BV
Published
2008-11
Volume
6
Issue
11
Pages
1243-1248
ISSN
1542-3565 (ISSN-L)
OpenAlex
W2021738092
Cited by
48
References
5
FWCI
1.75
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Placebo in Nonalcoholic Steatohepatitis: Insight Into Natural History and Implications for Future Clinical Trials. https://app.cochat.ai/papers/10.1016/j.cgh.2008.07.013
The paper
Loomba, R., Wesley, R., Pucino, F., Liang, T. J., Kleiner, D. E., & Lavine, J. E. (2008). Placebo in Nonalcoholic Steatohepatitis: Insight Into Natural History and Implications for Future Clinical Trials. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2008.07.013

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.